Search alternatives:
designed systems » designing systems (Expand Search), design system (Expand Search)
systems decrease » sizes decrease (Expand Search), step decrease (Expand Search)
largest decrease » larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
designed systems » designing systems (Expand Search), design system (Expand Search)
systems decrease » sizes decrease (Expand Search), step decrease (Expand Search)
largest decrease » larger decrease (Expand Search)
marked decrease » marked increase (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
The Laboratory Animal Flow Diagram.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
10
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
11
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
12
The structures of T3 and Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
13
Synthesis process of Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
14
ESI-HRMS spectra for Kylo-0603.
Published 2025“…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …”
-
15
Ray tracing of optical components in the RSSCA system: design and visualization of light paths.
Published 2025Subjects: -
16
The newly designed online consultation platform.
Published 2025“…</p><p>Results</p><p>Median LOS decreased by 62.5% (144–54 hours; p < 0.001), remaining stable during a 5-week pause. …”
-
17
-
18
-
19
-
20